Efficacy and Safety of the Glycine Transporter‐1 Inhibitor Org 25935 for the Prevention of Relapse in Alcohol‐Dependent Patients: A Randomized,Double‐Blind,Placebo‐Controlled Trial
1. Addiction Biology Unit, Institute of Neuroscience and Physiology, University of Gothenburg, , Gothenburg, Sweden;2. Merck, , Rahway, New Jersey;3. MSD, , Oss, the Netherlands